Holen Sie sich die Stockscreener-App
2.52
2.44%
0.06
Vorhandelsmarkt:
2.54
0.02
+0.79%
Schlusskurs vom Vortag:
$2.46
Offen:
$2.47
24-Stunden-Volumen:
174.45K
Relative Volume:
0.68
Marktkapitalisierung:
$49.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-0.63
EPS:
-4
Netto-Cashflow:
$-21.66M
1W Leistung:
-2.70%
1M Leistung:
-25.44%
6M Leistung:
-14.29%
1J Leistung:
+21.74%
1-Tages-Spanne:
$2.43
$2.67
1-Wochen-Bereich:
$2.42
$2.79
52-Wochen-Spanne:
$1.10
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Firmenname
Nrx Pharmaceuticals Inc
Sektor
Branche
Telefon
484-254-6134
Adresse
1201 ORANGE STREET, WILMINGTON
Vergleichen Sie NRXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.52 | 47.88M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Eingeleitet | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
Is a relief rally coming for NRx Pharmaceuticals Inc. Equity Warrant holdersSmart Stock Forecast Using AI Algorithms - Newser
NRx Pharmaceuticals Inc. stock trend outlook and recovery pathReal Chart Based Opportunity Identification - Newser
Using R and stats models for NRx Pharmaceuticals Inc. forecastingFree Breakout Confirmation With Entry Tracker - Newser
How to recover losses in NRx Pharmaceuticals Inc. Equity Warrant stockAI Stock Movement Forecast with Accuracy - Newser
Can machine learning forecast NRx Pharmaceuticals Inc. recoveryShort-Term Price Breakout Signal Analysis - Newser
Key metrics from NRx Pharmaceuticals Inc.’s quarterly dataPredictable Return Strategy with AI Support - Newser
Combining machine learning predictions for NRx Pharmaceuticals Inc. Equity WarrantGrowth Watchlist for Long Term Positioning - Newser
What machine learning models say about NRx Pharmaceuticals Inc. Equity WarrantFree Smart Trend Trading with Weekly Signals - Newser
Is NRx Pharmaceuticals Inc. stock bottoming outFree Risk Controlled Short Term Trade Plans - Newser
Relative strength of NRx Pharmaceuticals Inc. Equity Warrant in sector analysisTechnical Safety Zone Pattern Recognition - Newser
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - ACCESS Newswire
New Product Launches: Will They Boost NRx Pharmaceuticals Inc. Equity Warrant Stock in 2025Capital Safe Picks with Consistent Gains - Newser
Key resistance and support levels for NRx Pharmaceuticals Inc. Equity WarrantBuy Entry Confirmation Based on Technical Analysis - Newser
Trend analysis for NRx Pharmaceuticals Inc. this weekGrowth Summary Based on Market Positioning - Newser
Can NRx Pharmaceuticals Inc. recover in the next quarterTechnical Insight Guide for Safer Trades - Newser
Multi factor analysis applied to NRx Pharmaceuticals Inc. Equity WarrantBuy Point Strategy with Profit Protection - Newser
Is NRx Pharmaceuticals Inc. showing signs of accumulationFast Movement Forecast for Trading Success - Newser
Technical analysis overview for NRx Pharmaceuticals Inc. stockEntry Optimization Guide with Volume Analysis - Newser
Applying chart zones and confluence areas to NRx Pharmaceuticals Inc.Expert-Backed High Yield Stock Watchlist - Newser
NRx Pharmaceuticals Inc. Equity Warrant Company’s Quarterly Earnings Growth: What the Numbers SayFree Smart Money Tracking Signal Generator - Newser
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics(TM) Secures Florida Regulatory Clearance to Close Dura Medical Acquisition - ADVFN Brasil
HOPE Therapeutics receives Florida approval for Dura Medical acquisition By Investing.com - Investing.com Nigeria
NRx Secures Florida Approval to Acquire Veterans Mental Health Provider Dura Medical - Stock Titan
New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustai - Foster's Daily Democrat
Forecasting NRx Pharmaceuticals Inc. price range with options dataFree Trade Scanner With Buy Zone Alerts - Newser
NRx Pharmaceuticals Inc. stock chart pattern explainedFree Swing Trading Entry Point Signals - Newser
Statistical indicators supporting NRx Pharmaceuticals Inc.’s strengthMomentum Entry Alerts with Risk Control - Newser
NRX Pharmaceuticals Maintains 'Buy' Rating with $31.00 Price Target - AInvest
Actions to Remove Benzethonium Chloride from Ketamine Products in Favor of Safer and Superior Option in $750 Million Market, Projected to Reach $3.35 Billion by 2034: NRx Pharmaceuticals, Inc. - Barchart.com
NRx Pharmaceuticals’ (NRXP) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
Trendline Breach Raises Concern for NRx Pharmaceuticals Inc. InvestorsHigh Win Rate Trading Opportunities Detected - beatles.ru
NRx Pharmaceuticals (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products - TipRanks
NRx Pharmaceuticals' Strategic Move to Eliminate Benzethonium Chloride from Ketamine Products: A Regulatory Innovation Driving Market Capture in Mental Health Therapeutics - AInvest
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products - WV News
How volatile is NRx Pharmaceuticals Inc. stock compared to the marketExceptional market positioning - Jammu Links News
What drives NRx Pharmaceuticals Inc. Equity Warrant stock priceDouble-digit growth - Jammu Links News
Should I hold or sell NRx Pharmaceuticals Inc. stock in 2025Unbelievable profit margins - Jammu Links News
What is NRx Pharmaceuticals Inc. company’s growth strategyFree Buy/Sell Signal Notifications - Jammu Links News
Is NRx Pharmaceuticals Inc. a growth stock or a value stockBuild a portfolio that grows with the market - Jammu Links News
What MACD signals say about NRx Pharmaceuticals Inc.Free Investment Strategy With Low Risk - Newser
What catalysts could drive NRx Pharmaceuticals Inc. Equity Warrant stock higher in 2025Capitalize on momentum-driven investment opportunities - Jammu Links News
Does NRx Pharmaceuticals Inc. Equity Warrant stock perform well during market downturnsUnlock daily market insights for better trades - Jammu Links News
What is the dividend policy of NRx Pharmaceuticals Inc. stockInvest in stocks with long-term growth potential - Jammu Links News
Does NRx Pharmaceuticals Inc. stock perform well during market downturnsCapitalize on emerging market opportunities - Jammu Links News
Why is NRx Pharmaceuticals Inc. stock attracting strong analyst attentionBuild wealth faster with consistent growth stocks - Jammu Links News
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):